Bone and mineral metabolism in older adults with Parkinson's disease

Age and Ageing

Volumn 38, Issue 6, 2009, Pages 675-680

  Abou Raya, Suzan ^a   Helmii, Madihah ^b   Abou Raya, Anna ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Elderly; Older adults; Osteoporosis; Parkinson's disease

Indexed keywords

ALKALINE PHOSPHATASE; AMANTADINE; AMINO TERMINAL TELOPEPTIDE; ANTIPARKINSON AGENT; CALCIUM ION; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; VITAMIN D;

AGED; ARTICLE; BODY MASS; BONE METABOLISM; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FALLING; FEMALE; FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MINERAL METABOLISM; MONOTHERAPY; OSTEOPOROSIS; PARKINSON DISEASE; PHYSICAL CAPACITY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SUNLIGHT; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE DENSITY; CALCIUM, DIETARY; CASE-CONTROL STUDIES; COHORT STUDIES; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PARKINSON DISEASE; PEPTIDES; RISK FACTORS; SUNLIGHT; VITAMIN D;

EID: 70350689972     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afp137     Document Type: Article

References (30)

1. Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP. Epidemiology of Parkinson's disease. J Neurol 2008; 255: 18-32.
2. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-35.
3. Van Den Eeden SK, Tanner CM, Bernstein AL et al. Incidence of Parkinson's disease: Variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-22.
4. Kasten M, Chade A, Tanner CM. Epidemiology of Parkinson's disease. Handb Clin Neurol 2007; 83: 129.
5. Schrag A, Dodel R, Spottke A, Bornschein B, Siebert U, Quinn NP. Rate of clinical progression in Parkinson's disease: A prospective study. Mov Disord 2007; 22: 938-45.
6. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005; 20: S11-6.
7. Vaserman N. Parkinson's disease and osteoporosis. Joint Bone Spine 2005; 72: 484-8.
8. Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: A retrospective study. J Neurol Neurosurg Psychiatry 2006; 77: 468-73.
9. Pickering RM, Grimbergen YA, Rigney U et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord 2007; 22: 1892-900.
10. Sato Y, Kaji M, Tsuru T,Oizimi K. Risk factors for hip fracture among elderly patients with Parkinson's disease. J Neurol Sci 2001; 182: 89-93.
11. GeneverRW, Downes TW, Medcalf P. Fracture rates in Parkinson's disease compared with age and gender matched controls: A retrospective cohort study. Age Ageing 2005; 34: 21-4.
12. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with Parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 2007; 81: 153-61.
13. Khosla S, Riggs BL. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am 2005; 34: 1015-30.
14. Graafmans W, Ooms M, Bezemer P, Bouter L, Lips P. Different risk profiles for hip fractures and distal forearm fractures: A prospective study. Osteoporos Int 1996; 6: 427-31.
15. Cooper C, Melton LJ. Epidemiology of osteoporosis. Trends Endocrinol Metab 1992; 3: 224-9.
16. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. Bone mineral density in hip fracture patients with Parkinson's disease: A case-control study. Arch PhysMed Rehabil 2006; 87: 1459-62.
17. Fahn S, Elton RL, Members of the UPDRS Development Committee. The unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease: Florham Park. New Jersey: Macmillan Healthcare Information, 1987; 153-63.
18. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology 1967; 17: 427-42.
19. Guyatt GH, Sullivan MJ, Thompson PJ et al. The 6-min walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132; 919-23.
20. Podsiadlo D, Richardson S. The timed up and go: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142-8.
21. Hamilton A, Balnave R, Adams R. Grip strength reliability. J Hand Ther 1994; 7: 163-70.
22. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
23. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
24. Fink HA, Kuskowski MA, Orwoll ES, Cauley JA, Ensrud KE. Association between Parkinson's disease and low bone density and falls in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 2005; 53: 1559-64.
25. Taggart H, Crawford V. Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing 1995; 24: 326-8.
26. Van Well C, Vermeulen H, Van Den Bosch W. Falls, a community care perspective. Lancet 1995; 345: 1549-51.
27. Koller W, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol 1989; 2: 98-105.
28. Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1 alpha hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 66: 64-8.
29. Downey PA, Siegel MI. Bone biology and the clinical implications for osteoporosis. Phys Ther 2006; 86: 77-91.
30. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550-60.